Course Partners & Sponsors
Course Description | Precision Medicine: Concepts, Methods and Clinical Implementation
Course Themes
Latest Trends in Precision Medicine (PM)
|| Concepts and methods of Molecular Medicine | Signature genes and molecules to each patient’s mechanism of disease and response to environmental factors, food and drugs | Translating genomic data into clinical practice for healthcare improvement | Complementary and companion diagnostic tests tailoring diagnosis and therapy to each patient ||
PM Adoption, Regulation and Outcomes Monitoring
|| Healthcare organization models of Precision Medicine, cost effectiveness and metrics | Human resources, technologies, and infrastructures of Precision Medicine | Contribution of IT and digital health to Precision Medicine’s effects on outcomes | Artificial intelligence, interactive simulation and point of care technologies in Precision Medicine ||
PM Economics and Business Models
|| Companies developing clinical technologies and providing clinical services in Precision Medicine | Marketing and commercialization models, reimbursement/non-reimbursement markets | The economic models of Precision Medicine, including sustainable and scalable business | Blockchain technologies in the logistical management of Precision Medicine data ||
Clinical Case Studies: Precision Internal Medicine
|| Immune inflammatory, endocrine metabolic, and neurodegenerative disorders | LDTs identifying changes at key pathogenic pathways of patients | Diagnosis and therapy to each patient’s disease using molecular and genetic data ||
Clinical Case Studies: Precision Cancer Medicine
|| Most prevalent malignancies in lung, colorectal, breast, prostate and skin will be used to show how molecular biomarkers and genomic data from the tumor and the tumor microenvironment are associated with aggregated pathophysiological data to refine diagnosis and personalize therapy ||
Why You Should Attend?
Our Leadership
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus lacinia velit a feugiat finibus. Morbi iaculis diam id tellus iaculis, eu pretium metus fermentu
Fernando Vidal-Vanaclocha, MD, PhD
Chief Science Officer, Course Director
Physician scientist, trained in Pathology, and professor of Translational Molecular Medicine. He has extensive experience in discovery and translational research in Oncology, Inflammation and Regenerative Medicine. He has been vry interested in moving laboratory discoveries to applications and has founded several biotech entities in Spain (INBIOMED, PHARMAKINE, IMMA) and in the USA (BIOPHARMANCE and more recently, PERSONA BIOMED) all of them focused in the development and commercialization of products and services for molecular diagnosis and target-oriented therapeutics.
Currently, he is adjunct professor at the George Washington University School of Medicine, Washington, D.C.
(495) 235-2356
fv@personabiomed.com
Don Cooper
President & CEO, Course Planner
Former staff member of Chairman of the Science and Technology Committee of The U.S. House of Representatives. A securities trader and former Northern Virginia area real estate developer. He has held C-level positions in hospitality, IT, communications start-ups with most recent being, Regenera, LLC, a stem-cell company he founded with Dr. Yves Gerard Illouz of Paris, creator of liposuction.
